Literature DB >> 18752309

Attenuation of TCDD-induced oxidative stress by 670 nm photobiomodulation in developmental chicken kidney.

Jinhwan Lim1, Ruth A Sanders, Ronnie L Yeager, Deborah S Millsap, John B Watkins, Janis T Eells, Diane S Henshel.   

Abstract

2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD), a potent developmental teratogen inducing oxidative stress and sublethal changes in multiple organs, provokes developmental renal injuries. In this study, we investigated TCDD-induced biochemical changes and the therapeutic efficacy of photobiomodulation (670 nm; 4 J/cm(2)) on oxidative stress in chicken kidneys during development. Eggs were injected once prior to incubation with TCDD (2 pg/g or 200 pg/g) or sunflower oil vehicle control. Half of the eggs in each dose group were then treated with red light once per day through embryonic day 20 (E20). Upon hatching at E21, the kidneys were collected and assayed for glutathione peroxidase, glutathione reductase, catalase, superoxide dimutase, and glutathione-S-transferase activities, as well as reduced glutathione and ATP levels, and lipid peroxidation. TCDD exposure alone suppressed the activity of the antioxidant enzymes, increased lipid peroxidation, and depleted available ATP. The biochemical indicators of oxidative and energy stress in the kidney were reversed by daily phototherapy, restoring ATP and glutathione contents and increasing antioxidant enzyme activities to control levels. Photobiomodulation also normalized the level of lipid peroxidation increased by TCDD exposure. The results of this study suggest that 670 nm photobiomodulation may be useful as a noninvasive treatment for renal injury resulting from chemically induced cellular oxidative and energy stress.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18752309     DOI: 10.1002/jbt.20233

Source DB:  PubMed          Journal:  J Biochem Mol Toxicol        ISSN: 1095-6670            Impact factor:   3.642


  7 in total

Review 1.  The Effect of Low-Power Laser Therapy on the TGF/β Signaling Pathway in Chronic Kidney Disease: A Review.

Authors:  Behnaz Ahrabi; Maryam Bahrami; Reza Moghadasali; Mona Zamanian-Azodi; Maryam Sadat Khoramgah; Fatemeh Sadat Tabatabaei Mirakabad; Shahram Darabi; Hojjat Allah Abbaszadeh
Journal:  J Lasers Med Sci       Date:  2020-03-15

2.  Photobiomodulation Therapy Improves Acute Inflammatory Response in Mice: the Role of Cannabinoid Receptors/ATP-Sensitive K+ Channel/p38-MAPK Signalling Pathway.

Authors:  Laís M S Neves; Elaine C D Gonçalves; Juliana Cavalli; Graziela Vieira; Larissa R Laurindo; Róli R Simões; Igor S Coelho; Adair R S Santos; Alexandre M Marcolino; Maíra Cola; Rafael C Dutra
Journal:  Mol Neurobiol       Date:  2017-10-04       Impact factor: 5.590

3.  Effect of photobiomodulation on ischemia/reperfusion-induced renal damage in diabetic rats.

Authors:  Ahmad Asghari; Mohammad Ashrafzadeh Takhtfooladi; Hesam Aldin Hoseinzadeh
Journal:  Lasers Med Sci       Date:  2016-09-13       Impact factor: 3.161

4.  Acceleration of the meckel syndrome by near-infrared light therapy.

Authors:  Jinhwan Lim; Vincent H Gattone; Rachel Sinders; Caroline A Miller; Yun Liang; Peter Harris; John B Watkins; Diane S Henshel
Journal:  Nephron Extra       Date:  2011-11-25

Review 5.  Therapeutic Potential of Photobiomodulation for Chronic Kidney Disease.

Authors:  Ji Bian; Ann Liebert; Brian Bicknell; Xin-Ming Chen; Chunling Huang; Carol A Pollock
Journal:  Int J Mol Sci       Date:  2022-07-21       Impact factor: 6.208

6.  Photobiomodulation induced by 670 nm light ameliorates MOG35-55 induced EAE in female C57BL/6 mice: a role for remediation of nitrosative stress.

Authors:  Kamaldeen A Muili; Sandeep Gopalakrishnan; Janis T Eells; Jeri-Anne Lyons
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

7.  670-nm light treatment reduces complement propagation following retinal degeneration.

Authors:  Matt Rutar; Riccardo Natoli; Rizalyn Albarracin; Krisztina Valter; Jan Provis
Journal:  J Neuroinflammation       Date:  2012-11-26       Impact factor: 8.322

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.